2015 Annual Meeting & Associated Programs: 2015 international Sympsium on Cancer Immunotherapy - Featuring Today's Innovators, Tomorrow's Leadrs November 4, 2015 Gaylord National Hotel & Convention Center National Harbor, MDProgram SummaryOrganized by the Society for Immunotherapy of Cancer (SITC) in collaboration with the World Immunotherapy Council (WIC), these enduring materials from the 2015 International Symposium on Cancer Immunotherapy provided the opportunity for young scientists and emerging leaders in the field of cancer immunotherapy from throughout the world to interact, fulfilling WIC’s mission to facilitate rapid development and global dissemination of cancer immunotherapies through scientific exchange. The young investigators, each chosen for exemplary work in the field of cancer immunotherapy, contributed fresh insight and perspective into present and future issues surrounding immunotherapy of cancer (including immune targeting, escape, monitoring and treatments). Anticipated challenges and projected improvements as cancer immunotherapy is integrated into mainstream cancer treatment were also highlighted. Additionally, this forum provided a unique opportunity to showcase the world’s young, talented cancer immunotherapy scientists and provided an opportunity for knowledge exchange and networking with established experts. Target AudienceThe target audience for this program consisted of clinicians, basic and translational researchers, graduate students, post-doctoral fellows, and allied health professionals from academic institutions, industry and regulatory agencies who wished to learn more about the future of cancer immunotherapy research across the globe. #PrimaryCarePhysician #HeadandNeckCancers #SITC #Clinician #GastrointestinalCancers #Industry #Immunoscore #RegisteredNurse #Researcher #AlliedHealth #ImmuneCheckpointInhibitors #Oncologist #Pharmacist #AnnualMeeting #PresentationSlides #2016 #Biomarkers #ClinicalTrials #Leukemia #Lymphoma #Melanoma #ColonCancer #BreastCancers #AdoptiveCellTherapy #Ipilimumab #Video
Session II: Escape; Presentation: T Cell Exhaustion in Leukemia relapse Post Allogeneic Stem Cell Transplantation; Presenter: Hong Zheng, MD, PhD – Chinese American Hematologist and Oncologist Network (CAHON)00:15:34
Session III: Monitoring; Presentation: Immunoscore/Immunoprofiling in Melanoma; Presenter: Gabriele Madonna, PhD – Società Campana di ImmunoTerapia Oncologica (SCITO)00:16:34
Session IV: Therapy/Treatment; Presentation: Chimeric Antigen Receptor T Cells for Hematologic Tumors: Beyond CART-19; Presenter: Marco Ruella, MD – The Society for Immunotherapy of Cancer00:17:54
Session III: Monitoring; Presentation: Relationship between the Peripheral Immune Profile and Tumour Antigen T Cell Responses in Breast Cancer Patients; Presenter: Christopher Shipp, PhD – Progress in Vaccination against Cancer (PIVAC)00:16:09
Session IV: Therapy/Treatment; Presentation: Prognostic Significance of Peripheral Blood Cell Counts in Melanoma Patients; Presenter: Chiara Martinoli, PhD – European Institute of Oncology00:14:43
Session III: Monitoring; Presentation: Dynamic Changes of CD127 Expressing CD8+ Effector Memory and Terminal Effector Subsets in Head and Neck Squamous Cell Carcinoma; Presenter: Hsiang-Fong Kao, MD – The Chinese Oncology Society (COS)00:15:13
Session III: Monitoring; Presentation: The Predictive Value of Centre Tumour CD8+ T Cells in Patients with Hepatocellular Carcinoma: Comparison with Immunoscore; Presenter: Cheng Sun, MD, PhD – Committee for Tumor Immunology and Bio-Therapy, Chinese Society of Immunology (TIBIT, CSI)00:12:55
Session IV: Therapy/Treatment; Presentation: Ipilimumab Treatment Results in CD4 T Cell Activation that is Concomitant with a Reduction in Tregs and MDSCs; Presenter: Yago Pico de Coana, PhD – Scandinavian Network for Immunotherapy of Cancer (SNIC)00:12:08
Session I: Target; Presentation: Role of the Calcium Binding GPRC6a Receptor in Chemotherapy Mediated Immunogenic Cell Death Induced Tumor Control; Presenter: rer. Nat Dagmar Quandt, PhD – AKTuI - Arbeitskreis Tumorimmunologie (German Cancer Immunology group in the German Immunology Society) with Tumor Immunology Meets Oncology (TIMO)00:11:36
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us